GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr Lalchandani Labs Ltd (BOM:541299) » Definitions » Cyclically Adjusted Price-to-FCF

Dr Lalchandani Labs (BOM:541299) Cyclically Adjusted Price-to-FCF : (As of Jul. 08, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Dr Lalchandani Labs Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Dr Lalchandani Labs Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Dr Lalchandani Labs's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Lalchandani Labs Cyclically Adjusted Price-to-FCF Chart

Dr Lalchandani Labs Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Dr Lalchandani Labs Semi-Annual Data
Mar14 Mar15 Mar16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Dr Lalchandani Labs's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, Dr Lalchandani Labs's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr Lalchandani Labs's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dr Lalchandani Labs's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Dr Lalchandani Labs's Cyclically Adjusted Price-to-FCF falls into.


;
;

Dr Lalchandani Labs Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Dr Lalchandani Labs's Cyclically Adjusted FCF per Share for the fiscal year that ended in Mar25 is calculated as:

For example, Dr Lalchandani Labs's adjusted Free Cash Flow per Share data for the fiscal year that ended in Mar25 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar25 (Change)*Current CPI (Mar25)
=0.663/157.5517*157.5517
=0.663

Current CPI (Mar25) = 157.5517.

Dr Lalchandani Labs Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201603 -2.350 102.518 -3.612
201703 1.365 105.196 2.044
201803 -1.659 109.786 -2.381
201903 -4.653 118.202 -6.202
202003 -1.634 124.705 -2.064
202103 -2.534 131.771 -3.030
202203 2.097 138.822 2.380
202303 -0.701 146.865 -0.752
202403 -0.771 153.035 -0.794
202503 0.663 157.552 0.663

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Dr Lalchandani Labs  (BOM:541299) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Dr Lalchandani Labs Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Dr Lalchandani Labs's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Dr Lalchandani Labs Business Description

Traded in Other Exchanges
N/A
Address
Greater Kailash, Part-1, M-20, Basement, South Delhi, New Delhi, IND, 110048
Dr Lalchandani Labs Ltd engages in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunology, virology, cytology, and other pathological and radiological investigations. It also offers Immunoassay, Immuno-Histochemistry, Molecular Pathology, DNA, and Genetic Testing. Revenue is generated from the sale of services.

Dr Lalchandani Labs Headlines

No Headlines